Armata Pharmaceuticals, Inc.’s ARMP share price has dipped by 10.95%, which has investors questioning if this is right time ...

Fourth Quarter 2024 and Recent Developments: The Phase 2 Tailwind study represents the second successful clinical trial for AP-PA02, Armata's lead pulmonary candidate, which was first evaluated in ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...

In this randomized controlled trial, among hospitalized patients with a bloodstream infection, seven days of antibiotic ...

Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded. (Operator Instructions) I'd now like to hand the call over ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Berikut adalah penjelasan tentang tips dan cara menaikkan trombosit pada anak, makanan yang harus dihindari, serta supplemen ...

AAOS 2024 Annual Report: Forging the Path to the Future Read the 2024 Annual Report to explore a year of progress, innovation and commitment to the future of orthopaedics. Join HIPAA-Compliant ...

Let's go, new Bulldogs! After you have been accepted to Ferris State, your next step is completing orientation. Start online, then join us for an on-campus session. Your Ferris State degree is within ...